CMOS‐based implantable glucose monitoring device with improved performance and reduced invasiveness
Author(s) -
Kawamura T.,
Masuda K.,
Hirai T.,
Ohta Y.,
Motoyama M.,
Takehara H.,
Noda T.,
Sasagawa K.,
Tokuda T.,
Okitsu T.,
Takeuchi S.,
Ohta J.
Publication year - 2015
Publication title -
electronics letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.375
H-Index - 146
eISSN - 1350-911X
pISSN - 0013-5194
DOI - 10.1049/el.2015.0612
Subject(s) - cmos , sensitivity (control systems) , biomedical engineering , reduction (mathematics) , electronic engineering , materials science , optoelectronics , engineering , geometry , mathematics
An implantable glucose monitoring device based on a CMOS line sensor combined with a glucose‐responsive fluorescent hydrogel is developed. An implantable glucose monitoring device with sufficient sensitivity and response time is realised, which is an improvement over the authors' previous proof‐of‐concept device. A reduction of the sensor size made the device diameter injectable with a commercially available 16‐gauge syringe needle. The sensor's performance was confirmed through both in vitro and in vivo experiments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom